Dr. Agarwal's Health Care Statistics
Total Valuation
NSE:AGARWALEYE has a market cap or net worth of INR 116.31 billion. The enterprise value is 121.31 billion.
Market Cap | 116.31B |
Enterprise Value | 121.31B |
Important Dates
The last earnings date was Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NSE:AGARWALEYE has 316.16 million shares outstanding. The number of shares has increased by 13.23% in one year.
Current Share Class | 316.16M |
Shares Outstanding | 316.16M |
Shares Change (YoY) | +13.23% |
Shares Change (QoQ) | +1.91% |
Owned by Insiders (%) | 30.61% |
Owned by Institutions (%) | 4.69% |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 132.34 and the forward PE ratio is 96.71. NSE:AGARWALEYE's PEG ratio is 2.15.
PE Ratio | 132.34 |
Forward PE | 96.71 |
PS Ratio | 6.80 |
PB Ratio | 6.04 |
P/TBV Ratio | 17.24 |
P/FCF Ratio | 225.07 |
P/OCF Ratio | 32.28 |
PEG Ratio | 2.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.58, with an EV/FCF ratio of 234.73.
EV / Earnings | 145.35 |
EV / Sales | 7.09 |
EV / EBITDA | 26.58 |
EV / EBIT | 53.76 |
EV / FCF | 234.73 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.50.
Current Ratio | 1.66 |
Quick Ratio | 1.35 |
Debt / Equity | 0.50 |
Debt / EBITDA | 2.11 |
Debt / FCF | 18.59 |
Interest Coverage | 2.07 |
Financial Efficiency
Return on equity (ROE) is 6.61% and return on invested capital (ROIC) is 5.39%.
Return on Equity (ROE) | 6.61% |
Return on Assets (ROA) | 4.39% |
Return on Invested Capital (ROIC) | 5.39% |
Return on Capital Employed (ROCE) | 7.06% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 4,214 |
Asset Turnover | 0.53 |
Inventory Turnover | 14.56 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 389.96 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 49.10 |
Average Volume (20 Days) | 590,680 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AGARWALEYE had revenue of INR 17.11 billion and earned 834.60 million in profits. Earnings per share was 2.78.
Revenue | 17.11B |
Gross Profit | 7.49B |
Operating Income | 2.26B |
Pretax Income | 1.59B |
Net Income | 834.60M |
EBITDA | 4.56B |
EBIT | 2.26B |
Earnings Per Share (EPS) | 2.78 |
Balance Sheet
The company has 5.22 billion in cash and 9.61 billion in debt, giving a net cash position of -4.39 billion or -13.89 per share.
Cash & Cash Equivalents | 5.22B |
Total Debt | 9.61B |
Net Cash | -4.39B |
Net Cash Per Share | -13.89 |
Equity (Book Value) | 19.27B |
Book Value Per Share | 59.60 |
Working Capital | 3.16B |
Cash Flow
In the last 12 months, operating cash flow was 3.60 billion and capital expenditures -3.09 billion, giving a free cash flow of 516.80 million.
Operating Cash Flow | 3.60B |
Capital Expenditures | -3.09B |
Free Cash Flow | 516.80M |
FCF Per Share | 1.63 |
Margins
Gross margin is 43.76%, with operating and profit margins of 13.19% and 4.88%.
Gross Margin | 43.76% |
Operating Margin | 13.19% |
Pretax Margin | 9.28% |
Profit Margin | 4.88% |
EBITDA Margin | 26.67% |
EBIT Margin | 13.19% |
FCF Margin | 3.02% |
Dividends & Yields
NSE:AGARWALEYE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 0.95% |
Buyback Yield | -13.23% |
Shareholder Yield | n/a |
Earnings Yield | 0.72% |
FCF Yield | 0.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |